间歇性THA爆发刺激左侧前额叶皮质改善多药物使用障碍患者的认知功能:一项随机对照试验
Ling Dong1,2, Wen-Cai Chen1,2, Hang Su3
1Wuhan Mental Health Center, Wuhan, Hubei Province, China.
Frontiers in psychiatry
|June 12, 2023
概括
间歇性爆刺激 (iTBS) 改善了多重药物使用障碍患者的认知功能,优于10 Hz重复性跨磁刺激 (rTMS). 这种神经认知恢复可能涉及GABA-Aα5和IL-10水平的变化.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 成 药物 药物 药物 药物
背景情况:
- 滥用多种药物,特别是海洛因和甲基胺 (MA),导致严重的认知缺陷.
- 通过改变大脑刺激性和神经递质,重复性跨磁刺激 (rTMS) 显示出改善成中认知功能的潜力.
- 治疗药物成的最佳rTMS参数 (时间,位置,机制) 尚不清楚.
研究的目的:
- 与10 HzrTMS和假刺激相比,研究间歇性达爆发刺激 (iTBS) 在同时使用海洛因和MA使用障碍的患者中改善认知功能的有效性.
- 探索潜在的神经生物学机制是认知改善的基础,专注于特定的蛋白质变化.
主要方法:
- 56名患有多种药物使用障碍 (海洛因和MA) 的患者被随机分为三组:iTBS,10 Hz rTMS或假 iTBS,接受了针对左侧脊侧前额皮层 (DLPFC) 的20次治疗.
- 在治疗前和治疗后使用可重复电池评估神经心理状态 (RBANS) 评估认知功能.
- 使用ELISA量化EPI,GABA-Aα5和IL-10的血清水平,以与认知变化相关联.
主要成果:
- iTBS组的RBANS分数显著增加 (11.95分),特别是在记忆,注意力和社会认知方面 (p=0.05).
- 在iTBS后,血清EPI和GABA-Aα5水平下降,而IL-10增加. 立即的记忆改善与GABA-Aα5负相关,注意力与IL-10正相关.
- 与基线相比,10 Hz rTMS 组在总RBANS 评分和即时记忆中显示出统计学上显著的改善 (p<0.05),但这些效应比 iTBS 显著小.
- 在假 iTBS 组中没有观察到任何显著的认知变化.
结论:
- 在左侧的DLPFC进行间歇性甲突发刺激 (iTBS) 似乎是增强多重药物使用障碍患者神经认知恢复的有效干预措施.
- 与10 Hz的rTMS相比,iTBS在改善认知功能方面表现出更高的有效性.
- 观察到的认知改善可能与GABA-Aα5和IL-10血清水平的调节有关,这表明了潜在的治疗机制.
更多相关视频
06:42Continuous Theta Burst Stimulation of the Posterior Medial Frontal Cortex to Experimentally Reduce Ideological Threat Responses
Published on: September 28, 2018
11.7K
09:26Disruption of Frontal Lobe Neural Synchrony During Cognitive Control by Alcohol Intoxication
Published on: February 6, 2019
18.8K
相关概念视频
Blind Procedures
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...
Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
